FLASH THERAPEUTICS has a total of 17 patent applications. It decreased the IP activity by 83.0%. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are BALLIVET MARC, PACT PHARMA INC and SYNPLOID BIOTEK LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | Israel | 2 | |
#5 | Singapore | 2 | |
#6 | United States | 2 | |
#7 | China | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Enzymes | |
#5 | Measuring microorganism processes | |
#6 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Bouille Pascale | 14 |
#2 | Lamouroux Lucille | 12 |
#3 | Duthoit Christine | 7 |
#4 | Gayon Régis | 7 |
#5 | Iche Alexandra | 5 |
#6 | Moal Yohann | 1 |
#7 | Vergnault Hélène | 1 |
#8 | Pages Jean-Christophe | 1 |
#9 | Gayon Regis | 1 |
#10 | Bouillé Pascale | 1 |
Publication | Filing date | Title |
---|---|---|
SG11201810014UA | Viral particle for rna transfer, especially into cells involved in immune response |